Retatrutide and trizepatide represent a novel class of medications that act on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These multifunctional receptor https://tasneemcghb194878.answerblogs.com/profile